
iCardio.ai develops AI for the interpretation of Ultrasound imaging, with a focus on echocardiograms. Leveraging a proprietary dataset of over 200M annotated Ultrasound images, comprising possibly the largest privately-owned Ultrasound database in the world, iCardio.ai’s mission ushers in the most cutting-edge innovation in the realm of deep medicine. iCardio.ai serves several leading Ultrasound software and hardware companies, including GE Healthcare, in the research and development of AI algorithms. iCardio.ai’s establishment coincides with the recent explosive use of hand-held portable Ultrasound across all areas of healthcare, perhaps the largest shift in medical imaging since the invention of the X-Ray, to provide real-time interpretation of images either on-device or through the cloud. Setting the standard for deep learning within medical imaging and expanding its potential applications, iCardio.ai is bringing AI to Ultrasound.

iCardio.ai develops AI for the interpretation of Ultrasound imaging, with a focus on echocardiograms. Leveraging a proprietary dataset of over 200M annotated Ultrasound images, comprising possibly the largest privately-owned Ultrasound database in the world, iCardio.ai’s mission ushers in the most cutting-edge innovation in the realm of deep medicine. iCardio.ai serves several leading Ultrasound software and hardware companies, including GE Healthcare, in the research and development of AI algorithms. iCardio.ai’s establishment coincides with the recent explosive use of hand-held portable Ultrasound across all areas of healthcare, perhaps the largest shift in medical imaging since the invention of the X-Ray, to provide real-time interpretation of images either on-device or through the cloud. Setting the standard for deep learning within medical imaging and expanding its potential applications, iCardio.ai is bringing AI to Ultrasound.
Headquarters: Los Angeles, California
What they do: AI for automated interpretation of echocardiography/ultrasound imaging
Proprietary dataset: Reportedly >200 million ultrasound images
Regulatory milestones: FDA Breakthrough Device designation; parts of product cleared via FDA 510(k)
Company size: Approximately 14 employees (reported)
Clinical ultrasound interpretation (echocardiography) automation
Software Development
Latest reported round announced Aug 1, 2024
Company announced a strategic funding round led by BSD Enterprises
“Cedars-Sinai Accelerator; BSD Enterprises”
| Company |
|---|